Literature DB >> 22364704

Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic.

James R Roberts, Jena J Lee, Deborah A Marthers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364704     DOI: 10.1016/j.amjcard.2011.11.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  ACE Inhibitor-Related Angioedema: Are Your Patients at Risk?

Authors:  Michele B Kaufman
Journal:  P T       Date:  2013-03

2.  Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria.

Authors:  Nicola Bonner; Charlotte Panter; Alan Kimura; Rich Sinert; Joseph Moellman; Jonathan A Bernstein
Journal:  BMC Health Serv Res       Date:  2017-05-22       Impact factor: 2.655

3.  Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.

Authors:  Meihua Yan; Yumin Wen; Liping Yang; Xi'ai Wu; Xiaoguang Lu; Bingxuan Zhang; Weiping Huang; Ping Li
Journal:  Trials       Date:  2016-05-23       Impact factor: 2.279

4.  Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.

Authors:  Mengdi Wang; Zhen Wang; Jingwei Zhou; Weiwei Sun; Ying Wang; Mei Han; Hanwen Yang; Wei Jing Liu; Yaoxian Wang
Journal:  Trials       Date:  2018-07-17       Impact factor: 2.279

5.  Clinical efficacy and safety of Chinese herbal medicine for the treatment of patients with early diabetic nephropathy: A protocol for systematic review and meta-analysis.

Authors:  Xiaomei Yang; Chenling Hu; Shengju Wang; Qiu Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

6.  Angioedema Related to Angiotensin-Converting Enzyme Inhibitors: Attack Severity, Treatment, and Hospital Admission in a Prospective Multicenter Study.

Authors:  Nicolas Javaud; Jallal Achamlal; Paul-George Reuter; Frédéric Lapostolle; Akim Lekouara; Mustapha Youssef; Lilia Hamza; Ahmed Karami; Frédéric Adnet; Olivier Fain
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

7.  Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial.

Authors:  Xue-Min Zhao; Ying Zhang; Xin-Hui He; Hong-Dong Chen; Zhu-Feng Wang; Jing Guo; Xin-Miao Wang; Ze-Zheng Gao; Ji-Ping Wang; Wei Liu; Lin-Hua Zhao; Xiao-Lin Tong
Journal:  Trials       Date:  2018-03-27       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.